Patent · US Active

Compounds as cannabinoid receptor ligands

US8501794B2 · kind B2 · utility

9Cited by

7References

7Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

William A. Carroll · Evanston, US
Michael J. Dart · Highland Park, US
Teodozyj Kolasa · Lake Villa, US
Tongmei Li · Lake Bluff, US
Derek W. Nelson · Troy, US
Meena Patel · Libertyville, US
Sridhar Peddi · Grayslake, US
Arturo Perez-Medrano · Grayslake, US
Xueqing Wang · Evanston, US

Key dates

Filing date	Nov 4, 2009
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Nov 4, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present application relates to isothiazolylidene containing compounds of Formula (I)wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.